Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Launched by UNIVERSITY OF LATVIA · Jul 12, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to screen for gastric cancer by testing breath samples for specific chemicals, known as volatile organic compounds. The hope is that this method will help identify early signs of gastric cancer and related conditions, such as atrophic gastritis and H. pylori infection, by examining the breath of patients. The study will also explore how lifestyle factors, like diet and smoking, may affect the results.

To participate in the trial, you should be between the ages of 40 and 64, have been diagnosed with gastric cancer, or be part of a group with no symptoms but at average risk for the disease. You will need to give your consent and be in good physical condition to provide breath samples and undergo other procedures. The study is currently recruiting participants, and it promises to be an important step toward improving gastric cancer screening methods. If you're interested, you’ll receive detailed information about what to expect throughout the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with verified gastric cancer (Group 1 \& 2)
• • Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5)
• • Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4)
• • Motivation to participate in the study
• • Physical status allowing volatile marker sampling and other procedures within the protocol
• • Signed consent
• Exclusion Criteria:
• • Known other active cancer
• • Ventilation problems, airway obstruction
• • Unwillingness or inability to co-operate